Extremity Reconstruction Market By Type, By Biomaterials - Global Opportunity Analysis and Industry Forecast, 2014 - 2022

  • ID: 3934629
  • Report
  • Region: Global
  • 126 pages
  • Allied Analytics LLP
1 of 5

FEATURED COMPANIES

  • CONMED Corporation
  • Skeletal Dynamics LLC.
  • Smith & Nephew plc
  • Stryker Corporation
  • Wright Medical Group N.V.
  • MORE
Extremity Reconstruction Market By Type (Upper Extremity, Lower Extremity, Partial Shoulder Replacement, Total Standard Replacement, Stemless Total Shoulder Replacement, Total Reverse Replacement, Elbow, Hand and Wrist, Hind foot Fusion, Ankle Fusion, Ankle Replacement), Biomaterials (Metallic, Polymeric, Ceramic and Natural) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022

Extremities are external articulated organs, which execute various locomotive functions. The human body has four extremities, i.e., two upper limbs and two lower limbs. In the recent times, leading players have increased their focus on the extremity reconstruction market, as the joint reconstruction market especially hips and knee reconstruction segment has witnessed sluggish growth in the recent years. Extremity reconstruction market is a small segment of the orthopedic industry, but is the fastest growing market for reconstructive joint replacements. The world extremity reconstruction market was $1,833 million in 2015 and is expected to reach $3,041 million by 2022, growing at a CAGR of 7.5% from 2016 to 2022.

The world extremity reconstruction market is driven by increase in the number of joint disorders such as osteoarthritis and rheumatoid arthritis coupled with increase in geriatric population and rapid rise in lifestyle-related disorders, such as obesity and diabetes that lead to joint disorders. In addition, increasing awareness of patients for better treatment options and need for better quality of living are expected to propel the market. Changes in clinical practice patterns, technological advancements such as reversed shoulder instead of anatomic shoulder and ankle arthroplasty for treating ankle fusion, and development of minimally invasive techniques such as stemless shoulder implants are expected to boost the market growth. However, high cost factor and failures & complications associated with the surgery are expected to hamper the market growth.

The world extremity reconstruction market is segmented on the basis of product, biomaterial, and geography. Based on product, the market is segmented mainly into upper extremity reconstruction and lower extremity reconstruction. Upper extremity reconstruction segment is subsegmented into shoulder, elbow, and hand & wrist. Lower extremity reconstruction is subsegmented into foot & ankle. Shoulder replacement has the largest market share, owing to the largest patient population and technological advancements in shoulder implants such as reverse shoulder implants and stemless implants. Ankle replacement market is expected to grow at the fastest rate due to technological advancements in this sector and positive outcome of ankle replacement to regain movement of ankles. Based on biomaterial, the market is segmented into metallic, ceramic, polymer, and natural biomaterials. Metallic biomaterials segment has the highest share in the extremity reconstruction devices, as these are preferable biomaterials for joint replacement devices due to their strength. The geographical segmentation of the market includes North America, Europe, Asia-Pacific, and LAMEA. North America has the highest market share due to high awareness among patients, increased desire to improve quality of life, and technological advancements in extremity reconstruction devices in the region. Asia-Pacific is expected to witness maximum growth due to increasing expenditure on healthcare, improving healthcare infrastructure, and increasing awareness among patients.

Merger & acquisition is the mostly adopted strategy in the extremity reconstruction market. In October 2015, Wright Medical Group, Inc. and Tornier N.V. merged to form Wright Medical Group N.V. This helped Wright Medical Group N.V. to establish itself as a premier, high-growth extremities biologics company in the extremity reconstruction market. In the same year, Zimmer and Biomet merged to form Zimmer Biomet Holdings to enhance its product offerings in the extremity reconstruction market.

Below key market players are profiled in the report

DePuy Synthes (a wholly owned subsidiary of Johnson & Johnson)
Smith & Nephew plc
Stryker Corporation
Integra Lifesciences Holdings Corporation
Zimmer Biomet Holdings, Inc.
Wright Medical Group N.V.
CONMED Corporation
Acumed, Inc., Arthrex, Inc.
Skeletal Dynamics LLC.

KEY MARKET BENEFITS

The study provides an in-depth analysis of the world extremity reconstruction market along with current trends and future estimations to elucidate the imminent investment pockets.
The report provides a quantitative analysis from 2014 to 2022 to enable stakeholders to capitalize on the prevailing market opportunities.
Extensive analysis of products helps in understanding the types of products used across various geographies.
Competitive intelligence highlights the business practices followed by leading players across various regions.
Comprehensive analysis of geographical regions are provided to determine the prevailing opportunities in these geographies.
The key players of the world extremity reconstruction market have been profiled in the report, and their strategies have been analyzed thoroughly to understand the competitive outlook of the global market
Extensive analysis of the market is conducted by closely following key product positioning and monitoring the top contenders within the market framework.

Key market segments

The world extremity reconstruction market is segmented based on product, applications, biomaterial and geography.

World Extremity Reconstruction Market By Product

Upper Extremity Reconstruction
Shoulder
Partial Shoulder Replacement
Total Standard Replacement
Stemless Total Shoulder Replacement
Total Reverse Replacement
Elbow
Hand & Wrist
Lower Extremity Reconstruction
Foot Devices
Hind foot Fusion
Other Fusions
Ankle Reconstruction Devices
Ankle Fusion
Ankle Replacement
World Extremity Reconstruction Market By Biomaterial

Metallic Biomaterial
Ceramic Biomaterial
Polymeric Biomaterial
Natural Biomaterial
World Extremity Reconstruction

MARKET

BY GEOGRAPHY

North America
U.S.
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
South Korea
Malaysia
Rest of Asia-Pacific
LAMEA
Brazil
Israel
South Africa
Saudi Arabia
Others
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • CONMED Corporation
  • Skeletal Dynamics LLC.
  • Smith & Nephew plc
  • Stryker Corporation
  • Wright Medical Group N.V.
  • MORE
CHAPTER 1 INTRODUCTION

1.1 Report description
1.2 Key benefits
1.3 Research methodology

1.3.1 Secondary research
1.3.2 Primary research
1.3.3 Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

2.1 CXO Perspective

CHAPTER 3 MARKET OVERVIEW

3.1 Market Definition & Scope
3.2 Key Findings

3.2.1 Top Investment Pockets
3.2.2 Top Winning Strategies

3.3 Porters Five Forces Analysis

3.3.1 Bargaining power of suppliers
3.3.2 Bargaining power of buyers
3.3.3 Threat of new entrants
3.3.4 Intensity of rivalry
3.3.5 Threat of substitutes

3.4 Market Share Analysis, 2015
3.5 Market Dynamics

3.5.1 Drivers

3.5.1.1 Increasing incidences of joint disabling diseases, trauma anD sports injuries
3.5.1.2 Technological advancements in the field of extremity implants
3.5.1.3 Increasing awareness and patient preference to maintain an active lifestyle
3.5.1.4 Obesity and diabetes epidemic increasing the risk of degenerative joint diseases

3.5.2 Restraints

3.5.2.1 High cost of surgeries
3.5.2.2 Failure, complications, and revision of surgeries and lack of trained professionals

3.5.3 Opportunities

3.5.3.1 Huge market opportunities in the Asia-pacific region and developing countries
3.5.3.2 New product introductions with innovative technologies

CHAPTER 4 WORLD EXTREMITY RECONSTRUCTION MARKET, BY PRODUCT

4.1 Overview

4.1.1 Market size and forecast

4.2 Upper Extremity Reconstruction

4.2.1 Key market trend
4.2.2 Key growth factors and opportunities
4.2.3 Market size and forecast
4.2.4 Shoulder Replacement

4.2.4.1 Market size and forecast
4.2.4.2 Partial Shoulder Replacement

4.2.4.2.1 MARKET SIZE AND FORECAST

4.2.4.3 Total Standard Replacement

4.2.4.3.1 MARKET SIZE AND FORECAST

4.2.4.4 Stemless Total Shoulder Replacement

4.2.4.4.1 MARKET SIZE AND FORECAST

4.2.4.5 Total Reverse Replacement

4.2.4.5.1 MARKET SIZE AND FORECAST

4.2.4.6 Elbow replacement

4.2.4.6.1 MARKET SIZE AND FORECAST

4.2.4.7 Hand and wrist reconstruction

4.2.4.7.1 MARKET SIZE AND FORECAST

4.3 Lower Extremity Reconstruction

4.3.1 Key market trend
4.3.2 Key growth factors and opportunities
4.3.3 Market size and forecast
4.3.4 Foot Devices

4.3.4.1 Market size and forecast
4.3.4.2 Hindfoot Fusion Devices

4.3.4.2.1 MARKET SIZE AND FORECAST

4.3.4.3 Other fusion devices

4.3.4.3.1 MARKET SIZE AND FORECAST

4.3.5 Ankle Devices

4.3.5.1 Market size and forecast
4.3.5.2 Ankle fusion devices

4.3.5.2.1 MARKET SIZE AND FORECAST

4.3.5.3 Total Ankle replacement devices

4.3.5.3.1 MARKET SIZE AND FORECAST

CHAPTER 5 WORLD EXTREMITY RECONSTRUCTION MARKET, BY BIOMATERIAL

5.1 Overview

5.1.1 Market size and forecast

5.2 Metallic biomaterials

5.2.1 Market size and forecast

5.3 Ceramic biomaterials

5.3.1 Market size and forecast

5.4 Polymeric Biomaterials

5.4.1 Market size and forecast

5.5 Natural biomaterials

5.5.1 Market size and forecast

CHAPTER 6 WORLD EXTREMITY RECONSTRUCTION MARKET, BY GEOGRAPHY

6.1 Overview

6.1.1 Market size and forecast

6.2 North America

6.2.1 Key market trends
6.2.2 Key growth factors and opportunities
6.2.3 Market size and forecast
6.2.4 U.S. Market Size and Forecast
6.2.5 Canada: Market Size and Forecast
6.2.6 Mexico: Market Size and Forecast

6.3 Europe

6.3.1 Key market trends
6.3.2 Key growth factors and opportunities
6.3.3 Market size and forecast
6.3.4 Germany: Market Size and Forecast
6.3.5 France: Market Size and Forecast
6.3.6 U.K.: Market Size and Forecast
6.3.7 Italy: Market Size and Forecast
6.3.8 Spain: Market Size and Forecast
6.3.9 Rest of Europe: Market Size and Forecast

6.4 Asia-Pacific

6.4.1 Key market trends
6.4.2 Key growth factors and opportunities
6.4.3 Market size and forecast
6.4.4 Japan: Market Size and Forecast
6.4.5 China: Market Size and Forecast
6.4.6 India: Market Size and Forecast
6.4.7 South Korea: Market Size and Forecast
6.4.8 Malaysia: Market Size and Forecast
6.4.9 Rest of Asia-Pacific: Market Size and Forecast

6.5 LAMEA

6.5.1 Key market trends
6.5.2 Key growth factors and opportunities
6.5.3 Market size and forecast
6.5.4 Brazil: Market Size and Forecast
6.5.5 Israel: Market Size and Forecast
6.5.6 Saudi Arabia: Market Size and Forecast
6.5.7 South Africa: Market Size and Forecast
6.5.8 Rest of LAMEA: Market Size and Forecast

CHAPTER 7 COMPANY PROFILES

7.1 Acumed LLC

7.1.1 Company Overview
7.1.2 Company Snapshot
7.1.3 Operating Business Segments
7.1.4 Key Strategic Moves & Developments

7.2 Arthrex, INC.

7.2.1 Company Overview
7.2.2 Company Snapshot
7.2.3 Operating business segments
7.2.4 Key Strategic Moves & Developments

7.3 CONMED Corporation

7.3.1 Company Overview
7.3.2 Company Snapshot
7.3.3 Operating business segments
7.3.4 Business performance
7.3.5 Key Strategic Moves & Developments

7.4 Integra Lifesciences Holdings Corporation

7.4.1 Company Overview
7.4.2 Company Snapshot
7.4.3 Operating business segments
7.4.4 Business performance
7.4.5 Key Strategic Moves & Developments

7.5 Johnson & Johnson

7.5.1 Company Overview
7.5.2 Company Snapshot
7.5.3 Operating business segments
7.5.4 Business performance
7.5.5 Key Strategic Moves & Developments

7.6 Skeletal Dynamics LLC

7.6.1 Company Overview
7.6.2 Company Snapshot
7.6.3 Operating Business Segments

7.7 Smith & Nephew plc

7.7.1 Company Overview
7.7.2 Company Snapshot
7.7.3 Operating business segments
7.7.4 Business performance
7.7.5 Key Strategic Moves & Developments

7.8 Stryker Corporation

7.8.1 Company Overview
7.8.2 Company Snapshot
7.8.3 Operating business segments
7.8.4 Business performance
7.8.5 Key Strategic Moves & Developments

7.9 Wright Medical Group N.V.

7.9.1 Company Overview
7.9.2 Company Snapshot
7.9.3 Operating business segments
7.9.4 Business performance
7.9.5 Key Strategic Moves & Developments

7.10 Zimmer Biomet Holdings, Inc.

7.10.1 Company Overview
7.10.2 Company Snapshot
7.10.3 Operating business segments
7.10.4 Business performance
7.10.5 Key Strategic Moves & Developments
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • CONMED Corporation
  • Skeletal Dynamics LLC.
  • Smith & Nephew plc
  • Stryker Corporation
  • Wright Medical Group N.V.
  • MORE
A new report titled, "Extremity Reconstruction Market by Type and Biomaterial -Global Opportunity Analysis and Industry Forecast, 2014 -2022",states that the global extremity reconstruction market was $1,833 million in 2015 and is expected to reach $3,041 million by 2022, growing at a CAGR of 7.5% from 2016 to 2022. Shoulder reconstruction segment, which accounted for more than 70% in 2015, is expected to dominate the global market throughout the forecast period. North America held the leading position in 2015, and is expected to maintain this trend throughout.

The key drivers of the market include increase in incidence of joint disorders such as osteoarthritis & rheumatoid arthritis coupled with growth in geriatric population and global rise in the prevalence of diabetes & obesity. In addition, increase in awareness among patients about the benefits of small joint reconstruction implants and improvement of technology such as development of stemless shoulder implants, reverse shoulder implants, and ankle reconstruction implants that assist in regaining ankle mobility are expected to propel the market growth. However, unfavorable reimbursement scenario and complications associated with extremity reconstruction surgeries hamper the market growth.

Upper extremity reconstruction implants (such as elbow, radius, hand & wrist, and shoulder) was the leading market segment in 2015, due to increase in the incidences of small joint disorders such as arthritis and fracture. She further added. Ankle replacement segment is expected to grow at a CAGR of 17.4%, owing to technological advancements in this segment. Technological innovations in ankle replacement implants have improved ankle motion in contrast to ankle fusion that restricts movement. Natural biomaterials segment is expected to grow rapidly due to their biocompatible and biodegradable properties.

Key Findings of the extremity reconstruction market Study:

The shoulder replacement segment generated the highest revenue in 2015, and is projected to grow at a CAGR of 7.3%.
Stemless shoulder implants segment is projected to grow rapidly registering a CAGR of 20.0%.
Metallic biomaterial dominated the world extremity reconstruction devices market.
Total ankle replacement segment is expected grow at a CAGR of 17.4%.
In 2015, the U.S. led in the global extremity reconstruction market, accounting for more than 67% share in the overall market.
Germany accounted for about one-third share of the European extremity reconstruction market in 2015.
Indian extremity reconstruction devices market is expected to grow at a CAGR of 13.7%.
North America accounted for a major share in 2015, and is expected to maintain this trend throughout the forecast period. This is attributed to rise in prevalence of joint disorders coupled with increase in geriatric population, high awareness regarding the benefits of extremity reconstruction devices, favorable reimbursement rates, presence of innovative technologies, and quest for better quality of life in this region. However, the Asia-Pacific region is expected to grow rapidly owing to the presence of ample growth opportunities in terms of unmet medical needs for the treatment of small joint disorders, increase in awareness about the benefits of extremity reconstruction surgeries, and rise in acceptance of advanced technologies.

Some of the key players profiled in the report include DePuy Synthes (a wholly owned subsidiary of Johnson & Johnson), Stryker Corporation, Zimmer Biomet Holdings, Inc., Smith & Nephew plc., Integra Lifesciences Holdings Corporation, Wright Medical Group N.V., Acumed, Inc., Arthrex, Inc., CONMED Corporation, and Skeletal Dynamics LLC.
Note: Product cover images may vary from those shown
5 of 5
DePuy Synthes (a wholly owned subsidiary of Johnson & Johnson)
Smith & Nephew plc
Stryker Corporation
Integra Lifesciences Holdings Corporation
Zimmer Biomet Holdings, Inc.
Wright Medical Group N.V.
CONMED Corporation
Acumed, Inc., Arthrex, Inc.
Skeletal Dynamics LLC.
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll